WEE1 Inhibitor: Clinical Development

被引：0
|
作者：
Anthony Kong
Hisham Mehanna
机构：
[1] University of Birmingham,Institute of Head and Neck Studies (InHANSE)
[2] King’s College London,Comprehensive Cancer Centre
来源：
Current Oncology Reports | 2021年 / 23卷
关键词：
WEE1 inhibitor; Adavosertib; AZD1775; TP53 mutation; Biomarker; Clinical trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] WEE1 Inhibitor: Clinical Development
    Kong, Anthony
    Mehanna, Hisham
    CURRENT ONCOLOGY REPORTS, 2021, 23 (09)
  • [2] Preclinical development of PKMYT1 and WEE1 inhibitor combinations
    Gallo, David
    Shah, Fenil
    Stocco, Rino
    Baruah, Prasamit
    Fourtounis, Jimmy
    Kryczka, Rosie
    Hyer, Marc L.
    Roulston, Anne
    Marshall, C. Gary
    Zimmermann, Michal
    Morris, Stephen
    Zinda, Michael
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [3] WEE1 kinase inhibitor shows promise
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (10) : 593 - 593
  • [4] WEE1 kinase inhibitor shows promise
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2019, 16 : 593 - 593
  • [5] Clinical development of WEE1 inhibitors in gynecological cancers: A systematic review
    Schutte, Tim
    Embaby, Alaa
    Steeghs, Neeltje
    van der Mierden, Stevie
    van Driel, Willemien
    Rijlaarsdam, Martin
    Huitema, Alwin
    Opdam, Frans
    CANCER TREATMENT REVIEWS, 2023, 115
  • [6] Pediatric DDR inhibitor combinations: Are WEE1 there yet?
    Slotkin, Emily K.
    Ortiz, Michael V.
    Bender, Julia L. Glade L.
    CANCER, 2023, 129 (14) : 2132 - 2134
  • [7] Development and Characterization of a Wee1 Kinase Degrader
    Li, Zhengnian
    Pinch, Benika J.
    Olson, Calla M.
    Donovan, Katherine A.
    Nowak, Radosaw P.
    Mills, Caitlin E.
    Scott, David A.
    Doctor, Zainab M.
    Eleuteri, Nicholas A.
    Chung, Mirra
    Sorger, Peter K.
    Fischer, Eric S.
    Gray, Nathanael S.
    CELL CHEMICAL BIOLOGY, 2020, 27 (01) : 57 - +
  • [8] Discovery and development of a potent and highly selective WEE1 inhibitor IMP7068
    Cai, Sui Xiong
    Ma, Ning
    Wang, Xiaozhu
    Jiang, Yangzhen
    Zhang, Hongxia
    Guo, Mingchuan
    Zhou, Ruiyu
    Tian, Ye Edward
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy
    Fu, Siqing
    Wang, Yudong
    Keyomarsi, Khandan
    Meric-Bernstein, Funda
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (09) : 741 - 751
  • [10] Degrading Wee1
    Montoya, M
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2005, 12 (09): : 741 - 741
12345